Join the team
Find inspiration in rewarding work. Learn more about what drives us.
For more than 70 years, we have pursued scientific discoveries that help address unmet medical needs. Our commitment to advancing breakthroughs has produced a portfolio of specialty medicines with novel mechanisms of action. These first-in-class treatments add to Kyowa Kirin’s rich history of innovation.
Building on our legacy, we continue to apply pioneering science to address high unmet needs in our core therapeutic areas. We aim to deliver medicines where no adequate treatments currently exist.
Beyond our three core areas of expertise, we are partnering to study potential first-in-class medicines for serious diseases, like atopic dermatitis and asthma. We value industry partnerships that can help accelerate the delivery of new medicines.
Bone and Mineral
Hematologic Diseases / Hemoto Oncology
Rare Diseases
By clicking the Send button, you authorize Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents to contact you by mail and/or email to provide information on products, programs, services, and disease-state information and/or utilize your information for market research or analytics. Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute your personal information outside the above terms of consent.
Are you visiting this site from Canada? If so, consider visiting our Canadian site. It's designed to bring you up-to-date content.
Click "Leave Page" to visit the Kyowa Kirin Canada site.
Or click “OK” to stay on the Kyowa Kirin US site.